Literature DB >> 22961479

Expression of microRNA machinery proteins in different types of chronic rhinosinusitis.

Ya-Na Zhang1, Ping-Ping Cao, Xin-Hao Zhang, Xiang Lu, Zheng Liu.   

Abstract

OBJECTIVES/HYPOTHESIS: Dysregulation of microRNAs (miRNAs) has recently been shown in chronic rhinosinusitis (CRS), the biogenesis and function of which are modulated by miRNA machinery proteins. The expression of these proteins in inflammatory airway diseases is unclear. The aim of this study was to investigate the expression of miRNA machinery components in CRS. STUDY
DESIGN: Case-control experimental study.
METHODS: The mRNA expression levels of miRNA machinery components including Drosha, Dicer, protein activator of the interferon-induced protein kinase (PACT), human immunodeficiency virus transactivating response RNA-binding protein, fragile X mental retardation protein, and argonaute 2/eukaryotic translation initiation factor 2C, 2 in nasal biopsies from control, CRS without nasal polyps (CRSsNP), eosinophilic, and noneosinophilic CRS with nasal polyps (CRSwNP) subjects were determined by quantitative reverse transcription polymerase chain reaction. Immunohistochemical staining was employed to examine the protein expression of PACT and the cellular source of PACT.
RESULTS: Among the tested components, only PACT mRNA expression was found to be altered in CRS, the levels of which were upregulated in CRSwNP as compared with control. In comparison with control and CRSsNP, PACT protein expression was also significantly upregulated in CRSwNP, with a further increase in eosinophilic CRSwNP. PACT was mainly expressed in CD138(+) plasma cells. A higher percentage of PACT-positive plasma cells in total plasma cells was detected in eosinophilic CRSwNP than in noneosinophilic CRSwNP. PACT protein expression correlated with disease severity and eosinophil infiltration.
CONCLUSIONS: PACT may be associated with the plasma cell function and eosinophilic inflammation in CRSwNP. However, further experimentation is needed to clarify the functions of PACT.
Copyright © 2012 The American Laryngological, Rhinological, and Otological Society, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22961479     DOI: 10.1002/lary.23517

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  5 in total

1.  MicroRNA expression profile of mature dendritic cell in chronic rhinosinusitis.

Authors:  Zu-Xia Ma; Xi Tan; Yang Shen; Xia Ke; Yu-Cheng Yang; Xing-Bo He; Zhi-Hai Wang; Yu-Bing Dai; Su-Ling Hong; Guo-Hua Hu
Journal:  Inflamm Res       Date:  2015-09-04       Impact factor: 4.575

Review 2.  MicroRNA in chronic rhinosinusitis and allergic rhinitis.

Authors:  Xin-Hao Zhang; Ya-Na Zhang; Zheng Liu
Journal:  Curr Allergy Asthma Rep       Date:  2014-02       Impact factor: 4.806

3.  ICON: chronic rhinosinusitis.

Authors:  Claus Bachert; Ruby Pawankar; Luo Zhang; Chaweewan Bunnag; Wytske J Fokkens; Daniel L Hamilos; Orathai Jirapongsananuruk; Robert Kern; Eli O Meltzer; Joaquim Mullol; Robert Naclerio; Renata Pilan; Chae-Seo Rhee; Harumi Suzaki; Richard Voegels; Michael Blaiss
Journal:  World Allergy Organ J       Date:  2014-10-27       Impact factor: 4.084

4.  The Expression of AGO2 and DGCR8 in Idiopathic Sudden Sensorineural Hearing Loss.

Authors:  Soon Young Han; Shin Kim; Dong-Hoon Shin; Jae Hyun Cho; Sung-Il Nam
Journal:  Clin Exp Otorhinolaryngol       Date:  2014-11-14       Impact factor: 3.372

5.  MicroRNA-761 suppresses remodeling of nasal mucosa and epithelial-mesenchymal transition in mice with chronic rhinosinusitis through LCN2.

Authors:  Jinzhang Cheng; Junjun Chen; Yin Zhao; Jingpu Yang; Kai Xue; Zonggui Wang
Journal:  Stem Cell Res Ther       Date:  2020-04-09       Impact factor: 6.832

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.